Amryt announces senior appointment
Irish-listed orphan drug developer Amryt Pharma has appointed Kieran Rooney as its vice-president of strategic alliances and licensing.
In his role, Mr Rooney will be responsible for assessing new acquisition and in-licensing opportunities. Mr Rooney has over 25 years of experience in the biopharmaceutical industry, with significant expertise in business development and commercial strategy. Before joining Amryt, he founded Halo BioConsulting, a global healthcare advisory services firm focusing on business alliances and management consulting. Prior to that, Mr Rooney worked as a consultant for the UK government and held business development roles at companies including Smith & Nephew, F2G Limited, Pharsight Corporation, and MDS Pharma Services.